Annual Retained Earnings
-$301.19 M
-$50.73 M-20.26%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual retained earnings is -$301.19 million, with the most recent change of -$50.73 million (-20.26%) on December 31, 2023.
- During the last 3 years, CUE annual retained earnings has fallen by -$147.91 million (-96.49%).
- CUE annual retained earnings is now -15516.22% below its all-time high of -$1.93 million, reached on December 31, 2015.
Performance
CUE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$332.37 M
-$8.66 M-2.68%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly retained earnings is -$332.37 million, with the most recent change of -$8.66 million (-2.68%) on September 30, 2024.
- Over the past year, CUE quarterly retained earnings has dropped by -$8.66 million (-2.68%).
- CUE quarterly retained earnings is now -3366.86% below its all-time high of -$9.59 million, reached on December 31, 2016.
Performance
CUE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CUE Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.3% | -2.7% |
| 3 y3 years | -96.5% | -32.7% |
| 5 y5 years | -319.5% | -32.7% |
CUE Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.5% | at low | -68.3% | at low |
| 5 y | 5-year | -177.6% | at low | -206.3% | at low |
| alltime | all time | <-9999.0% | at low | -3366.9% | at low |
Cue Biopharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$332.37 M(+2.7%) |
| Jun 2024 | - | -$323.71 M(+3.2%) |
| Mar 2024 | - | -$313.54 M(+4.1%) |
| Dec 2023 | -$301.19 M(+20.3%) | -$301.19 M(+4.7%) |
| Sep 2023 | - | -$287.75 M(+4.0%) |
| Jun 2023 | - | -$276.75 M(+5.0%) |
| Mar 2023 | - | -$263.56 M(+5.2%) |
| Dec 2022 | -$250.46 M(+26.8%) | -$250.46 M(+6.2%) |
| Sep 2022 | - | -$235.86 M(+4.9%) |
| Jun 2022 | - | -$224.91 M(+6.2%) |
| Mar 2022 | - | -$211.70 M(+7.2%) |
| Dec 2021 | -$197.45 M(+28.8%) | -$197.45 M(+4.4%) |
| Sep 2021 | - | -$189.06 M(+7.4%) |
| Jun 2021 | - | -$176.07 M(+6.2%) |
| Mar 2021 | - | -$165.79 M(+8.2%) |
| Dec 2020 | -$153.28 M | -$153.28 M(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -$142.18 M(+7.6%) |
| Jun 2020 | - | -$132.15 M(+8.9%) |
| Mar 2020 | - | -$121.32 M(+11.8%) |
| Dec 2019 | -$108.50 M(+51.1%) | -$108.50 M(+9.0%) |
| Sep 2019 | - | -$99.58 M(+7.6%) |
| Jun 2019 | - | -$92.59 M(+11.5%) |
| Mar 2019 | - | -$83.07 M(+15.7%) |
| Dec 2018 | -$71.80 M(+118.8%) | -$71.80 M(+19.3%) |
| Sep 2018 | - | -$60.18 M(+26.4%) |
| Jun 2018 | - | -$47.63 M(+18.1%) |
| Mar 2018 | - | -$40.34 M(+22.9%) |
| Dec 2017 | -$32.82 M(+242.3%) | -$32.82 M(+46.6%) |
| Sep 2017 | - | -$22.38 M(+29.0%) |
| Jun 2017 | - | -$17.35 M(+81.0%) |
| Dec 2016 | -$9.59 M(+397.1%) | -$9.59 M |
| Dec 2015 | -$1.93 M | - |
FAQ
- What is Cue Biopharma annual retained earnings?
- What is the all time high annual retained earnings for Cue Biopharma?
- What is Cue Biopharma annual retained earnings year-on-year change?
- What is Cue Biopharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cue Biopharma?
- What is Cue Biopharma quarterly retained earnings year-on-year change?
What is Cue Biopharma annual retained earnings?
The current annual retained earnings of CUE is -$301.19 M
What is the all time high annual retained earnings for Cue Biopharma?
Cue Biopharma all-time high annual retained earnings is -$1.93 M
What is Cue Biopharma annual retained earnings year-on-year change?
Over the past year, CUE annual retained earnings has changed by -$50.73 M (-20.26%)
What is Cue Biopharma quarterly retained earnings?
The current quarterly retained earnings of CUE is -$332.37 M
What is the all time high quarterly retained earnings for Cue Biopharma?
Cue Biopharma all-time high quarterly retained earnings is -$9.59 M
What is Cue Biopharma quarterly retained earnings year-on-year change?
Over the past year, CUE quarterly retained earnings has changed by -$8.66 M (-2.68%)